Medical information Clinical review pending

Genetic Testing

KRT74 Gene Hypotrichosis Type 3 Genetic Test

Genetic test using Next Generation Sequencing (NGS) to analyze the KRT74 gene for mutations associated with Hypotrichosis Type 3, a condition causing abnormal hair growth. Recommended for individuals with unexplained hair loss or a family history of the condition.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample or saliva sample. Confirm specific requirements with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: No special preparation is typically required for this test. Confirm with the laboratory before booking.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the KRT74 Gene Hypotrichosis Type 3 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Unexplained hair thinning or loss
✓Family history of hair loss
✓Suspected Hypotrichosis Type 3
✓Early onset hair loss
✓Reduced hair density
✓Genetic counseling for family members

In plain language

What this test helps you understand

This test helps identify specific genetic mutations in the KRT74 gene associated with Hypotrichosis Type 3, aiding in diagnosis and guiding management strategies for individuals with abnormal hair growth.

The KRT74 Gene Hypotrichosis Type 3 NGS Genetic DNA Test is a diagnostic tool used to identify genetic changes in the KRT74 gene linked to hypotrichosis, a condition affecting hair growth. This test uses advanced Next Generation Sequencing (NGS) technology to examine the gene for specific mutations. Understanding these genetic factors is important for managing and treating hair loss conditions. This test specifically looks for mutations in the KRT74 gene, which plays a role in hair follicle development. Detecting these mutations can help confirm a diagnosis of hypotrichosis type 3, guiding appropriate medical care and interventions. This test is particularly relevant for individuals experiencing unexplained hair thinning or loss, especially if there is a family history of similar conditions. Symptoms might include thinning hair on the scalp, reduced hair density, or early onset hair loss. Family members with a known history of KRT74 gene mutations may also benefit from testing. Taking this test can lead to an early diagnosis, enabling personalized treatment plans and informed decisions about hair restoration. It also facilitates access to genetic counseling for affected individuals and their families. Results are typically available within 3 to 4 weeks, and a genetic counselor can help interpret the findings and discuss implications.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is typically required for this test. Confirm with the laboratory before booking.

SampleBlood sample or saliva sample. Confirm specific requirements with the laboratory before booking.

MethodologyNext Generation Sequencing (NGS) is used to analyze the KRT74 gene for mutations.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test specifically analyzes the KRT74 gene. It may not detect mutations in other genes associated with hair loss. Results should be interpreted in conjunction with clinical findings and family history. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Hypotrichosis Type 3 is a genetic condition characterized by abnormal hair growth, often resulting in thinning hair or reduced hair density. It is associated with mutations in the KRT74 gene.

Individuals experiencing unexplained hair loss, especially with a family history of the condition, or those with symptoms like thinning hair or reduced density, may benefit from this test.

The test involves analyzing a sample of your blood or saliva using Next Generation Sequencing (NGS) technology to look for specific mutations in the KRT74 gene.

Results are typically available within 3 to 4 weeks. A genetic counselor can assist with interpreting the results.

This test can provide an early diagnosis, guide personalized treatment options, and inform decisions regarding hair restoration and genetic counseling for family members.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp